Takahiro Tsuchikawa

Dr. Takahiro Tsuchikawa

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2019 in Cancer Science
Verified
Journal Article
Open access
PDF file
SKShota Kuwabara
Shota Kuwabara
TTTakahiro Tsuchikawa
Takahiro Tsuchikawa
TNToru Nakamura
Toru Nakamura
YHYutaka Hatanaka
Yutaka Hatanaka
KHKanako C Hatanaka
Kanako C Hatanaka
SHSatoshi Hirano
Satoshi Hirano
The efficacy of preoperative neoadjuvant chemoradiotherapy (NAC) in cases of pancreatic cancer with extremely poor prognoses has been reported. In this study, we aimed to identify novel biomarkers that reflect prognoses following chemoradiotherapy using tertiary lymphoid organs (TLO) expressed in the tumor microenvironment. Resected tumor specimens were obtained from 140 pancreatic cancer patients. We retrospectively investigated the clinical relevance of TLO by categorizing patients into those who underwent upfront surgery (surgery first [SF]) and those who received NAC. The immunological elements within TLO were analyzed by immunohistochemistry (IHC). In the IHC analysis, the proportions of CD8+ T lymphocytes, PNAd+ high endothelial venules, CD163+ macrophages and Ki‐67+ cells within the TLO were higher in the NAC group than in the SF group. In contrast, the proportion of programmed cell death‐1+ immunosuppressive lymphocytes within TLO was lower in the NAC group than in the SF group. The NAC group demonstrated favorable prognoses compared with the SF group. In the multivariate analysis, the TLO/tumor ratio was determined as an independent predictive prognostic factor. In conclusion, the administration of preoperative chemoradiotherapy may influence the immunological elements in the tumor microenvironment and result in favorable prognoses in pancreatic ductal adenocarcinoma patients.

6 August 2011 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
TTTakahiro Tsuchikawa
Takahiro Tsuchikawa
MMMasaki Miyamoto
Masaki Miyamoto
YYYoshiyuki Yamamura
Yoshiyuki Yamamura
TSToshiaki Shichinohe
Toshiaki Shichinohe
SHSatoshi Hirano
Satoshi Hirano
SKSatoshi Kondo
Satoshi Kondo

13 April 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
TUTakashi Ueno
Takashi Ueno
TTTakahiro Tsuchikawa
Takahiro Tsuchikawa
KHKanako C. Hatanaka
Kanako C. Hatanaka
YHYutaka Hatanaka
Yutaka Hatanaka
TMTomoko Mitsuhashi
Tomoko Mitsuhashi
SHSatoshi Hirano
Satoshi Hirano
Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma

28 June 2014 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
YYYoshiyuki Yamamura
Yoshiyuki Yamamura
TTTakahiro Tsuchikawa
Takahiro Tsuchikawa
KMKengo Miyauchi
Kengo Miyauchi
STShintaro Takeuchi
Shintaro Takeuchi
MWMasataka Wada
Masataka Wada
SHSatoshi Hirano
Satoshi Hirano

24 February 2011 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
TTTakahiro Tsuchikawa
Takahiro Tsuchikawa
HIH. Ikeda
H. Ikeda
YCY. Cho
Y. Cho
MMM. Miyamoto
M. Miyamoto
TST. Shichinohe
T. Shichinohe
SKS. Kondo
S. Kondo
Oesophageal cancer is one of the most aggressive tumours with a poor prognosis. However, little is known about the immune response in the tumour microenvironment. To investigate the role of immunosurveillance in the clinical course of oesophageal squamous cell carcinoma, 98 formalin-fixed, paraffin-embedded primary tumours were analysed using immunohistochemical methods for human leucocyte antigen (HLA) class I heavy chain and β2-microglobulin expression and for CD4-, CD8- and CD57-positive cell infiltration. HLA class I expression of tumour cells was correlated positively with infiltration of CD8+ T cells into the cancer nest, but not with the clinical course of disease. However, CD8+ and CD4+ T cell infiltration was correlated with prognosis. These results suggest that tumour antigen-specific cellular immune response plays a role in the clinical course of the disease and that HLA class I antigen expressed on tumour cells contribute to this association most probably by mediating the interactions between tumour cells and CD8+ T cells.

9 June 2016 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
TNTakehiro Noji
Takehiro Noji
TTTakahiro Tsuchikawa
Takahiro Tsuchikawa
KOKeisuke Okamura
Keisuke Okamura
KTKimitaka Tanaka
Kimitaka Tanaka
YNYoshitsugu Nakanishi
Yoshitsugu Nakanishi
SHSatoshi Hirano
Satoshi Hirano